Introduction: Medical Dictionary for Regulatory Activities (MedDRA) is a medical coding dictionary which is designed in order to be used by regulatory authorities, pharmaceutical companies, clinical research organizations and health care professionals, i.e. all participants in the system of medicines safety monitoring. Methods: This article describes process which is used for medical coding in clinical data management and, in brief, most commonly used medical dictionary MedDRA. The purpose of this paper is a modest contribution to easier and more successful understanding of the encoding process in clinical data management in the fi eld of pharmacovigilance. Topic: MedDRA Development, structure, multi-axiality, availability of foreign languages, as well as common problems faced by medical coding expert while coding were presented. Conclusion: MedDRA has become the standard medical terminology for drug regulators and pharmaceutical companies in Montenegro. Training should be provided to all coders in order to achieve the optimum level of coding and to ensure that all the parameters for quality are achieved. Coding should be treated as one of the most important function in clinical research.
INTRODUCTION
Th ere are numerous dictionaries used for classifying medicines, adverse reactions, and medical conditions, but Medical Dictionary for Regulatory Activities (MedDRA) is important and commonly used dictionary in the fi eld of medicines safety monitoring,too MedDRA is a medical coding dictionary developed by Maintenance and Support Services Organisation (MSSO) [1] . MedDRA is supported by International Conference on Harmonisation (ICH) on Technical Requirements for Registration of Pharmaceuticals for Human use. ICH's powerful tool, MedDRA is available to all for use in the registration, documentation and safety monitoring of medical products both before and aft er a product has been authorised for sale. Products covered by the scope of Med-DRA include pharmaceuticals, biologics, vaccines and drug-device combination products. Today, its growing use worldwide by regulatory authorities, pharmaceutical companies, clinical research organisations and health care doi:10.5937/hpimj1502266M professionals allows better global protection of health of a patient [2] .
MeDRA is available to anyone who is willing to use it, although in 1999, when it was initially implemented, most users were from Europe, Japan and USA[2]:
• Medical terms generated during all phases of clinical trial, excluding animal toxicology, as well as post-marketing and pharmacovigilance data • Th erapeutic indications (including signs, symptoms, diseases, diagnosis, or prophylaxis of disease, and modifi cation of functions)
• Coding names and quantitative results of investigations, surgical procedures and medical/ social/family history.
Th e terminology is used through the entire regulatory process, from pre-marketing to post-marketing, and for data entry, retrieval, evaluation, and presentation [3] [4] .
METHODOLOGY
Th is article describes process which is used for medical coding in clinical data management and, in brief, most commonly used medical dictionary MedDRA. Th e purpose of this paper is a modest contribution to easier and more successful understanding of the encoding process in clinical data management in the fi eld of pharmacovigilance.
TOPIC

MedDRA Development
Prior to development of MedDRA, there was no internationally accepted medical terminology for biopharmaceutical regulatory purposes. Most organizations dealing with regulatory aff airs, has used some of international terminology for adverse drug reactions in combination with the terminology of morbidity. Th erefore, for example in Europe, the World Health Organization's Adverse Reaction Terminology (WHO-ART) in combination with International Classifi cation of Diseases Ninth Revision (ICD-9) was used. In the USA Coding Symbols for a Th esaurus of Adverse Reaction Terms (COSTART) in combination with modifi ed ICD-9 was used, while in Japan Japanese Adverse Reaction Terminology (J-ART) was developed. Additionally, many organizations have modifi ed this terminology, in order to adapt it to their own needs. Hence, the use of diff erent terminology in various stages of the life cycle of a drug complicate the data analysis [5] . For example, data relating to safety in clinical trials are the most commonly classifi ed using ICD terminology, while J-ART, WHO ART or COSTART were used during post-marketing surveillance [1] . Th e need for a standardised medical terminology was identifi ed by the ICH in the 1990s, since there was not a standard terminology available that provided the scope and level of granularitys needed by regulatory authorities and industry [6] . In the past, the terminologies in use, such as the FDA's COSTART, WHO-ART, J-ART, H-ARTS, ICD-9 and ICD-9CM were updated so infrequently that individual users created their own version and standardisation was lost. MedDRA was based on a terminology belonging to the Medicines and Healthcare products Regulatory Agency (MHRA) of UK (Medicines and Healthcare products Regulatory Agency -MHRA) [7] . In October 1994 ICH adopted MEDDRA Version 1.0 as basis for international terminology. An ICH M1 Expert Working Group was formed to further develop the terminology. Version 1.0 was released for alpha testing by pharmaceutical companies and regulatory authorities. In February 1996, ICH agreed to the Version 2.0 and renamed the terminology MedDRA for Medical Dictionary for Regulatory Activities in July 1997 [8] .
Maintenance and Support Services Organization
Under the oversight of the ICH MedDRA Management Board, the key function of the MSSO is to maintain, distribute, and support MedDRA on behalf of MedDRA users [9] . Th e MSSO staff includes [9] 
Volume 2 • Number 2 • May 2015 • HOPH
MedDRA is used in over 60 countries, among which is Montenegro. MedDRA global success is refl ected in continuing development in order to adapt to the new scientifi c knowledge and requirements of the regulator. MedDRA releases 2 versions in a year -one in March and the second in September. One can obtain access to the MedDRA terminology annually, by renewable subscription. Each subscription brings all MedDRA updates that incorporate approved changes and additions. Th e current version is 18.0, from March 2015.
MedDRA Structure
Th e structure of MedDRA is very logical. Th ere are fi ve levels (Fig. 1) Terms are grouped into 26 System Organ Class (SOC) based on etiology (e.g., Infections and infestations), the place of origin (e.g. Gastrointestinal disorders), or purpose, or purposes (e.g., Surgical or medical procedures). Th ere is also a SOC relating to social conditions or circumstances.
MedDRA Multi-axiality
MedDRA is a multi-axial terminology meaning that a Preferred Term (PT) may be linked to more than one SOC.
[10] For example, PT infl uenza has a link to both SOC Respiratory, thoracic and mediastinal disorders (its organ system of manifestation) and to SOC Infections and infestations (Fig. 2) . Each PT is assigned a primary SOC to avoid "double counting" while retrieving information from all SOCs (i.e., a cumulative SOC-by -SOC data output). Th e other SOCs to which a multi-axial PT is linked are called "secondary" SOCs [11] .
MedDRA available in foreign languages
In addition to the original English master and Japanese translation, MedDRA has been translated and is maintained in the following languages: Chinese, Czech, Dutch, French, German, Hungarian, Italian, Portuguese and www.hophonline.org Spanish. Each MedDRA term has an associated 8-digit numerical code which remains the same irrespective of the language. Multiple languages allow a large number of users to operate in their native language which promotes accuracy and precision in assigning codes. Th is interoperability is very powerful and allows easy sharing of data internationally [1] . In order to code it is needed to split the terms.
• Event is recorded without mentioning the site, e.g. ulcer is recorded without additional information like moth ulcer, leg ulcer, etc.
• Multiple medical concepts recorded which had surgical procedure and reason for injury. However the reason or cause or site of injury is not clear.
• A medication term reported however allergy due to the medication or outcome of the allergy is not specifi ed.
CONCLUSION
MedDRA has become the standard medical terminology for drug regulators and pharmaceutical companies in over 60 countries, among which is Montenegro. MedDRA allows easy communications with others and is a powerful tool for public health monitoring. Availability in multiple languages makes it accessible to the widest numbers of users. Guidelines for investigators, coding rules and medical validation should be provided to all coders in order to achieve the optimum level of coding and to ensure that all the parameters for quality are achieved [13] , [14] . Since the coding should be treated as one of the most important function in clinical research, it is necessary to minimize the problems faced by medical coding expert when coding.
